Nextgen Biomed Ltd (NXGN)
Nov 10, 2023 - NXGN was delisted (reason: acquired by Thoma Bravo)
23.94
+0.03 (0.13%)
Inactive · Last trade price on Nov 8, 2023

NextGen Healthcare Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Nov '23 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
22381925
Upgrade
Market Cap Growth
-29.63%-29.63%-66.99%-60.24%-21.50%1013.23%
Upgrade
Enterprise Value
22261724
Upgrade
Last Close Price
0.170.160.351.072.694.48
Upgrade
PB Ratio
-2.91-2.65-9.392.222.9311.59
Upgrade
P/TBV Ratio
---2.524.5011.42
Upgrade
Debt / Equity Ratio
-0.09-0.09----
Upgrade
Quick Ratio
0.050.050.114.1613.944.03
Upgrade
Current Ratio
0.080.080.194.1714.124.06
Upgrade
Return on Equity (ROE)
---251.97%-52.21%-18.57%-32.29%
Upgrade
Return on Assets (ROA)
-728.92%-728.92%-43.30%-11.62%-11.10%-16.19%
Upgrade
Return on Capital (ROIC)
---58.20%-13.62%-12.90%-20.65%
Upgrade
Earnings Yield
-68.11%-74.79%-154.43%-31.54%-4.22%-1.63%
Upgrade
FCF Yield
-30.13%-33.09%-48.29%-10.13%-4.40%-1.95%
Upgrade
Buyback Yield / Dilution
-15.90%-15.90%-0.53%-8.67%-22.66%-12.16%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q